Australia; NSW
Between 2013 and 2016 drug companies in Australia spent more than $34 million supporting consumer groups, but what is the real cost of all that support? Australian experts say consumer groups funded by drug companies might be placed in a position to overemphasise the benefits and downplay the harms of their sponsors’ products, ultimately putting consumers at risk. They argue sponsorship of consumer groups could also allow direct marketing to patients through a back door, and could shift the focus of community groups from patients and health to their own corporate interests.
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Sign In
